<?xml version='1.0' encoding='UTF-8'?>
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Front Aging Neurosci</journal-id>
      <journal-id journal-id-type="iso-abbrev">Front Aging Neurosci</journal-id>
      <journal-id journal-id-type="publisher-id">Front. Aging Neurosci.</journal-id>
      <journal-title-group>
        <journal-title>Frontiers in Aging Neuroscience</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1663-4365</issn>
      <publisher>
        <publisher-name>Frontiers Media S.A.</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">31572164</article-id>
      <article-id pub-id-type="pmc">6753164</article-id>
      <article-id pub-id-type="doi">10.3389/fnagi.2019.00241</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Neuroscience</subject>
          <subj-group>
            <subject>Original Research</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Structural and Functional Disruptions in Subcortical Vascular Mild Cognitive Impairment With and Without Depressive Symptoms</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Lyu</surname>
            <given-names>Hanqing</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="author-notes" rid="fn001">
            <sup>†</sup>
          </xref>
          <uri xlink:type="simple" xlink:href="https://loop.frontiersin.org/people/737874/overview"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>Jianjun</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
          <xref ref-type="author-notes" rid="fn001">
            <sup>†</sup>
          </xref>
          <uri xlink:type="simple" xlink:href="https://loop.frontiersin.org/people/740659/overview"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Xu</surname>
            <given-names>Jinping</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
            <sup>3</sup>
          </xref>
          <uri xlink:type="simple" xlink:href="https://loop.frontiersin.org/people/355675/overview"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zheng</surname>
            <given-names>Haotao</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yang</surname>
            <given-names>Xiaoyan</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lin</surname>
            <given-names>Songjun</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>Jianxiang</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <uri xlink:type="simple" xlink:href="https://loop.frontiersin.org/people/491457/overview"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zhou</surname>
            <given-names>Liuchang</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hu</surname>
            <given-names>Yuanming</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="corresp" rid="c001">
            <sup>*</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Guo</surname>
            <given-names>Zhouke</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
          <xref ref-type="corresp" rid="c001">
            <sup>*</sup>
          </xref>
          <uri xlink:type="simple" xlink:href="https://loop.frontiersin.org/people/740665/overview"/>
        </contrib>
      </contrib-group>
      <aff id="aff1"><sup>1</sup><institution>Department of Radiology, Shenzhen Traditional Chinese Medicine Hospital/The Fourth Clinical Medical College, Guangzhou University of Chinese Medicine</institution>, <addr-line>Shenzhen</addr-line>, <country>China</country></aff>
      <aff id="aff2"><sup>2</sup><institution>Department of Neurology and Psychology, Shenzhen Traditional Chinese Medicine Hospital/The Fourth Clinical Medical College, Guangzhou University of Chinese Medicine</institution>, <addr-line>Shenzhen</addr-line>, <country>China</country></aff>
      <aff id="aff3"><sup>3</sup><institution>Institute of Biomedical and Health Engineering, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences</institution>, <addr-line>Shenzhen</addr-line>, <country>China</country></aff>
      <author-notes>
        <fn fn-type="edited-by">
          <p>Edited by: Panteleimon Giannakopoulos, Université de Genève, Switzerland</p>
        </fn>
        <fn fn-type="edited-by">
          <p>Reviewed by: Sven Haller, Affidea CDRC, Switzerland; Jie Lu, Xuanwu Hospital, Capital Medical University, China; Chuanming Li, Chongqing Medical University, China</p>
        </fn>
        <corresp id="c001">*Correspondence: Yuanming Hu <email>tomhu163@163.com</email> Zhouke Guo <email>szzyygzk@126.com</email></corresp>
        <fn fn-type="other" id="fn001">
          <p><sup>†</sup>These authors have contributed equally to this work</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub">
        <day>13</day>
        <month>9</month>
        <year>2019</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2019</year>
      </pub-date>
      <volume>11</volume>
      <elocation-id>241</elocation-id>
      <history>
        <date date-type="received">
          <day>20</day>
          <month>5</month>
          <year>2019</year>
        </date>
        <date date-type="accepted">
          <day>19</day>
          <month>8</month>
          <year>2019</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright © 2019 Lyu, Wang, Xu, Zheng, Yang, Lin, Chen, Zhou, Hu and Guo.</copyright-statement>
        <copyright-year>2019</copyright-year>
        <copyright-holder>Lyu, Wang, Xu, Zheng, Yang, Lin, Chen, Zhou, Hu and Guo</copyright-holder>
        <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Many previous studies have revealed structural and functional abnormalities in patients with the subcortical vascular mild cognitive impairment (svMCI). Although depression symptoms were suggested to serve as a potential marker of conversion to dementia in patients with svMCI, whether these disruptions or other new findings will be identified in the svMCI comorbid with depression symptoms has not been established. In the current study, we combined voxel-based morphometry (VBM) and the resting-state functional magnetic resonance imaging (fMRI) to investigate the structural and functional disruptions in the svMCI with and without depression symptoms using a cohort of 18 svMCI with depression symptoms (svMCI+D), 17 svMCI without depression symptoms (svMCI−D), and 23 normal controls (NC). As a result, we identified significantly decreased gray matter density in the left parahippocampus (ParaHIPP.L), the right hippocampus (HIPP.R), and the right middle cingulate cortex (MCC.R) in both svMCI+D and svMCI−D compared to NC. Most importantly, we also identified increased gray matter density in the MCC.R accompanied by increased resting-state functional connectivity (RSFC) with right parahippocampus (ParaHIPP.R) in the svMCI+D compared to svMCI−D. Moreover, the gray matter density of MCC.R and ParaHIPP.L was correlated with cognitive impairments and depression symptoms in the svMCI, respectively. In conclusion, these results extended previous studies and added weight to considerations of depression symptoms in the svMCI. Moreover, we suggested that a processing loop associated with HIPP, ParaHIPP, and MCC might underlie the mechanism of depression symptoms in the svMCI.</p>
      </abstract>
      <kwd-group>
        <kwd>vascular mild cognitive impairment</kwd>
        <kwd>subcortical impairments</kwd>
        <kwd>cerebral small vessel disease</kwd>
        <kwd>subthreshold depression</kwd>
        <kwd>resting-state functional magnetic resonance imaging</kwd>
        <kwd>voxel-based morphometry</kwd>
      </kwd-group>
      <counts>
        <fig-count count="3"/>
        <table-count count="2"/>
        <equation-count count="0"/>
        <ref-count count="41"/>
        <page-count count="8"/>
        <word-count count="5374"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec sec-type="introduction" id="s1">
      <title>Introduction</title>
      <p>The subcortical vascular mild cognitive impairment (svMCI) is a nonamnestic subtype of MCI, which is characterized by extensive white matter hyperintensities (WMH) and multiple lacunar infarctions on magnetic resonance imaging (MRI; Frisoni et al., <xref rid="B5" ref-type="bibr">2002</xref>). Recently, more and more attention was paid to svMCI since it is regarded as a prodromal stage of subcortical vascular dementia (SVaD; Frisoni et al., <xref rid="B5" ref-type="bibr">2002</xref>; Seo et al., <xref rid="B31" ref-type="bibr">2010</xref>; Kim et al., <xref rid="B13" ref-type="bibr">2011</xref>) but is potentially reversible by managing the risk factors and drug treatments (Ravaglia et al., <xref rid="B25" ref-type="bibr">2006</xref>; Jak et al., <xref rid="B8" ref-type="bibr">2009</xref>). Compared to other risk factors, depression symptoms were underestimated even though it is common in people with MCI (Palmer et al., <xref rid="B20" ref-type="bibr">2007</xref>; Solfrizzi et al., <xref rid="B32" ref-type="bibr">2007</xref>; Enache et al., <xref rid="B2" ref-type="bibr">2011</xref>; Orgeta et al., <xref rid="B19" ref-type="bibr">2015</xref>; Liu et al., <xref rid="B18" ref-type="bibr">2019</xref>). Recently, a study reported that the prevalence of depression was highest in MCI (up to 18.8%) and was associated with different cognitive domains (Vloeberghs et al., <xref rid="B35" ref-type="bibr">2018</xref>). In fact, depression symptoms, even at minimal severity, have been reported to be associated with progression from MCI to dementia (Gabryelewicz et al., <xref rid="B7" ref-type="bibr">2007</xref>; Teng et al., <xref rid="B34" ref-type="bibr">2007</xref>; Palmer et al., <xref rid="B21" ref-type="bibr">2010</xref>; Rosenberg et al., <xref rid="B27" ref-type="bibr">2013</xref>). Moreover, Kim et al. (<xref rid="B12" ref-type="bibr">2013</xref>) suggested that depression symptoms might serve as a potential marker of conversion to dementia in patients with svMCI. Therefore, it is important and useful to investigate the structural and functional disruptions in the svMCI with and without depression symptoms (svMCI+D and svMCI−D, respectively).</p>
      <p>To date, too many previous studies have revealed structural and functional abnormalities in patients with svMCI regardless of depression symptoms. Specially, gray matter volume reductions in a wide range of cortical regions (e.g., superior and middle frontal gyrus, medial prefrontal gyrus, superior and inferior temporal gyrus), as well as in the subcortical regions (e.g., hippocampus, parahippocampal gyrus, thalamus, and caudate; Yi et al., <xref rid="B39" ref-type="bibr">2012</xref>; Li et al., <xref rid="B15" ref-type="bibr">2017</xref>) were reported in the svMCI. Besides gray matter reductions, cortical thinning in the inferior frontal and orbitofrontal gyri, the anterior cingulate, the insula, the superior temporal gyrus, and the lingual gyrus were also identified in the svMCI (Seo et al., <xref rid="B31" ref-type="bibr">2010</xref>; Lee et al., <xref rid="B14" ref-type="bibr">2018</xref>). Additionally, svMCI patients also presented decreased functional amplitude of spontaneous low-frequency oscillations in the default mode network (Yi et al., <xref rid="B39" ref-type="bibr">2012</xref>), altered functional connectivity of the posterior cingulate cortex (Ding et al., <xref rid="B1" ref-type="bibr">2015</xref>), and altered functional connectivity of the thalamus (Zhou et al., <xref rid="B40" ref-type="bibr">2016</xref>). However, whether these disruptions or other new findings will be identified in the svMCI comorbid with depression symptoms has not been established.</p>
      <p>In the current study, we combined voxel-based morphometry (VBM) and the resting-state functional magnetic resonance imaging (fMRI) to investigate the structural and functional disruptions in the svMCI with and without depression symptoms using a cohort of 18 svMCI+D, 17 svMCI−D, and 23 normal controls (NC).</p>
    </sec>
    <sec sec-type="materials and methods" id="s2">
      <title>Materials and Methods</title>
      <sec id="s2-1">
        <title>Participants</title>
        <p>We recruited 40 right-handed patients with svMCI from the Department of Encephalopathy and Psychology in Shenzhen Traditional Chinese Medicine Hospital. The diagnosis criteria of svMCI was performed by two experienced neurologists in consensus according to the modified Petersen’s criteria (Petersen, <xref rid="B23" ref-type="bibr">2004</xref>; Yi et al., <xref rid="B38" ref-type="bibr">2015</xref>; Jia et al., <xref rid="B9" ref-type="bibr">2016</xref>), which included the following: (1) patients who reported cognitive impairments involving memory and/or other cognitive domains lasting for at least 3 months; (2) objective cognitive impairments, although not meeting the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria for dementia; (3) a clinical dementia rating (CDR) = 0.5; (4) with a Montreal Cognitive Assessment (MOCA) score &lt;26; (5) normal or minimum impairments of daily life activities (Yi et al., <xref rid="B39" ref-type="bibr">2012</xref>); and (6) subcortical vascular causes of the cognitive impairments according to: (a) at least three supratentorial subcortical small infarcts (diameters ranging from 3 to 20 mm) with or without white matter lesions (WMLs) of any degree, or moderate to severe WML (score ≥2 according to the Fazekas rating scale; Fazekas et al., <xref rid="B3" ref-type="bibr">1987</xref>) with/without small infarct, or one or more strategically located subcortical small infarcts in the caudate nucleus, globus pallidus, or thalamus in the T2 fluid-attenuated inversion recovery (FLAIR) images; (b) absence of cortical and watershed infarcts, hemorrhages, hydrocephalus, and WMLs with specific causes (e.g., multiple sclerosis); and (c) no hippocampal or entorhinal cortex atrophy (scored 0 according to the medial temporal lobe atrophy scale of Scheltens; Scheltens and van de Pol, <xref rid="B30" ref-type="bibr">2012</xref>). All the patients were native Chinese, with ages from 50 to 70 years. Moreover, all svMCI patients underwent a global mental functioning through the MOCA. The severity of depression symptoms was assessed using the 17-item Hamilton Depression Rating Scale (HAMD). Patients with HAMD-17 scores 7–17 were classified into the svMCI+D, and those who scored less than 7 were classified into the svMCI−D (Riedel et al., <xref rid="B26" ref-type="bibr">2010</xref>; Zimmerman et al., <xref rid="B41" ref-type="bibr">2013</xref>; Pavlovic et al., <xref rid="B22" ref-type="bibr">2016</xref>).</p>
        <p>We also excluded patients who had: (1) severe aphasia and physical disabilities that may preclude completion of neuropsychological testing; (2) disorders with use of medications that may affect cognition; (3) a score of HAMD &gt;17; (4) schizophrenia; (5) strokes within 3 months; (6) inherited or inflammatory small vessel disease; (7) clinically significant diseases, such as gastrointestinal, renal, hepatic, respiratory, infectious, endocrine, or cardiovascular system disease; (8) cancer, alcoholism, and drug addiction; (9) known hypersensitivity to celery; and (10) inability to undergo a brain MRI. To ensure consistent application of the criteria and minimize diagnostic variability, we used a central neuroimaging reader to determine eligibility.</p>
        <p>Twenty-three age-, gender-, and education-matched NC were also included in the study, who had no history of any neurological or psychiatric disorders, no cognitive complaints, and no abnormalities in their conventional brain MRI images. During the research, three svMCI patients were excluded for personal reasons, and two controls and two svMCI patients were excluded for visible head motion. Thus, 18 svMCI+D patients, 17 svMCI−D patients, and 23 NC were included in the final analysis. The demographic and clinical data are shown in <xref rid="T1" ref-type="table">Table 1</xref>. All subjects gave written informed consent, and the study was approved by the Institutional Review Board of the Shenzhen Traditional Chinese Medicine Hospital.</p>
        <table-wrap id="T1" position="float">
          <label>Table 1</label>
          <caption>
            <p>Demographic data and clinical measures.</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th align="left" rowspan="1" colspan="1">Groups</th>
                <th align="center" rowspan="1" colspan="1">svMCI+D</th>
                <th align="center" rowspan="1" colspan="1">svMCI−D</th>
                <th align="center" rowspan="1" colspan="1">NC</th>
                <th align="center" rowspan="1" colspan="1"><italic>F</italic>-value</th>
                <th align="center" rowspan="1" colspan="1"><italic>p</italic>-value</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" rowspan="1" colspan="1">Subjects</td>
                <td align="center" rowspan="1" colspan="1">18</td>
                <td align="center" rowspan="1" colspan="1">17</td>
                <td align="center" rowspan="1" colspan="1">23</td>
                <td align="center" rowspan="1" colspan="1">-</td>
                <td align="center" rowspan="1" colspan="1">-</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Age</td>
                <td align="center" rowspan="1" colspan="1">61.66 ± 6.49</td>
                <td align="center" rowspan="1" colspan="1">65.82 ± 7.16</td>
                <td align="center" rowspan="1" colspan="1">61.91 ± 4.86</td>
                <td align="center" rowspan="1" colspan="1">2.601</td>
                <td align="center" rowspan="1" colspan="1">0.083</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Gender</td>
                <td align="center" rowspan="1" colspan="1">8:10</td>
                <td align="center" rowspan="1" colspan="1">9:8</td>
                <td align="center" rowspan="1" colspan="1">9:14</td>
                <td align="center" rowspan="1" colspan="1">-</td>
                <td align="center" rowspan="1" colspan="1">0.685</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Education</td>
                <td align="center" rowspan="1" colspan="1">7.66 ± 3.77</td>
                <td align="center" rowspan="1" colspan="1">8.70 ± 3.83</td>
                <td align="center" rowspan="1" colspan="1">9.82 ± 3.55</td>
                <td align="center" rowspan="1" colspan="1">1.728</td>
                <td align="center" rowspan="1" colspan="1">0.187</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">MOCA</td>
                <td align="center" rowspan="1" colspan="1">18.83 ± 1.68</td>
                <td align="center" rowspan="1" colspan="1">20.23 ± 2.33</td>
                <td align="center" rowspan="1" colspan="1">27.91 ± 1.04</td>
                <td align="center" rowspan="1" colspan="1">171.88</td>
                <td align="center" rowspan="1" colspan="1">&lt;0.001<sup>a,b,c</sup></td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">HAMD</td>
                <td align="center" rowspan="1" colspan="1">11.38 ± 2.50</td>
                <td align="center" rowspan="1" colspan="1">4.88 ± 1.31</td>
                <td align="center" rowspan="1" colspan="1">2.30 ± 1.55</td>
                <td align="center" rowspan="1" colspan="1">126.124</td>
                <td align="center" rowspan="1" colspan="1">&lt;0.001<sup>a,b,c</sup></td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <p><italic>ANOVA showed significant differences in the Montreal Cognitive Assessment (MOCA) and Hamilton Depression Rating Scale (HAMD) scores. a–c: <italic>post hoc</italic> analysis revealed the source of ANOVA (a: svMCI+D vs. NC, b: svMCI−D vs. NC, and c: svMCI+D vs. svMCI−D). Abbreviation: ANOVA, analysis of variance</italic>.</p>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec id="s2-2">
        <title>MRI Acquisition</title>
        <p>MRI scanning was conducted on a 3T scanner (GE medical system, MR750). The scanning parameters of the fMRI images were as follows: repetition time/echo time ratio = 2,000/35 ms, flip angle = 90°, matrix size = 64 × 64, slice thickness = 4 mm, voxel size = 4 × 4 × 4 mm<sup>3</sup>, and volumes = 240. The scanning parameters of the T1 images were as follows: repetition time/echo time ratio = 8.656/3.22 ms, inversion time = 450 ms, flip angle = 12°, matrix size = 256 × 256, slice thickness = 1 mm, voxel size = 1 × 1 × 1 mm<sup>3</sup>, and sections = 152. The scanning parameters of the T2 FLAIR images were as follows: repetition time/echo time ratio = 9,000/92.544 ms, flip angle = 160°, matrix size = 256 × 224, slice thickness = 6.5 mm, and voxel size = 0.47 × 0.47 × 6.5 mm<sup>3</sup>.</p>
      </sec>
      <sec id="s2-3">
        <title>VBM Analysis</title>
        <p>VBM analysis was performed to determine brain structural differences among the three groups. The structural MRI images were preprocessed using the DPABI toolbox<xref ref-type="fn" rid="fn0001"><sup>1</sup></xref>. The steps were as follows: (1) each T1 image was segmented into gray matter, white matter, and cerebrospinal fluid using a fully automated algorithm within DPABI; (2) all images were subsequently transformed to the Montreal Neurological Institute (MNI) space using DARTEL normalization; (3) the resulting images were smoothed with a Gaussian kernel of 6-mm full width at half maximum (FWHM = 6 mm); and (4) the modulated images were used to calculate the gray matter density and were corrected for total intracranial volume.</p>
      </sec>
      <sec id="s2-4">
        <title>Resting-State fMRI Data Preprocessing</title>
        <p>Preprocessing of the resting-state fMRI data was also performed using DPABI. For each participant, the preprocessing steps were as follows: (1) the first 10 volumes of each functional time series were discarded to allow for magnetization equilibrium; (2) the slice times for the remaining 230 images were corrected, and they were realigned to the first volume to account for head motion (subjects with head motion exceeding 3 mm in any dimension or 3° of angular motion through the resting-state run were removed); (3) all data were spatially normalized to the MNI template and resampled to 3 × 3 × 3 mm<sup>3</sup>; (4) spatial smoothing was performed using FWHM = 6 mm; (5) linear and quadratic trends were removed; (6) the Friston 24-parameter model (Friston et al., <xref rid="B6" ref-type="bibr">1996</xref>) was utilized to regress out head motion effects from the realigned data (Satterthwaite et al., <xref rid="B29" ref-type="bibr">2013</xref>; Yan et al., <xref rid="B37" ref-type="bibr">2013</xref>); (7) the white matter, cerebrospinal fluid, and global signals were regressed out; (8) temporal band-pass filtering (0.01–0.1 Hz) was performed; and (9) “scrubbed” was used to eliminate the bad images, captured before two time points and after one time point, which exceeded the preset criteria [frame displacement (FD), &lt;0.5] for excessive motion (Power et al., <xref rid="B24" ref-type="bibr">2012</xref>).</p>
      </sec>
      <sec id="s2-5">
        <title>Statistical Analysis of Demographic and Clinical Measures</title>
        <p>Demographic and clinical measures were analyzed using one-way analysis of variance (ANOVA) with Bonferroni correction, while gender was analyzed using <italic>χ</italic><sup>2</sup> using SPSS 19 (SPSS Inc., Chicago, IL, USA). The source of the differences between the means of the three groups was examined by <italic>post hoc</italic>
<italic>t</italic>-tests.</p>
      </sec>
      <sec id="s2-6">
        <title>Group Difference of Gray Matter Density</title>
        <p>Group difference of gray matter density was tested using analysis of covariance (ANCOVA) among svMCI+D, svMCI−D, and NC, while controlling for age, education, and gender. Gaussian random field (GRF) corrections were used for all multicomparison correction (a voxel-level of <italic>p</italic> &lt; 0.001 and a cluster-level of <italic>p</italic> &lt; 0.05). Then, the mean gray matter density in the altered clusters was calculated, separately, in the three groups. Group differences were compared among the three groups using ANCOVA and <italic>post hoc</italic>
<italic>t</italic>-tests between any two groups using SPSS.</p>
      </sec>
      <sec id="s2-7">
        <title>Resting-State Functional Connectivity (RSFC) Analyses</title>
        <p>To investigate the corresponding functional connectivity patterns of each altered brain region, we also performed RSFC analysis among the three groups. The RSFC of each altered region was defined by Pearson correlation coefficients between the mean time series of each seed region and that of each voxel in the rest of the brain. We used the binary gray matter mask in SPM before computing the whole brain RSFC. Correlation coefficients were converted to <italic>z</italic>-values using Fisher’s <italic>z</italic> transformation to improve normality.</p>
        <p>Group difference of the RSFC was tested using ANCOVA among svMCI+D, svMCI−D, and NC, while controlling for age, education, and gender. GRF corrections were used for all multicomparison correction (a voxel level of <italic>p</italic> &lt; 0.001 and a cluster-level of <italic>p</italic> &lt; 0.05).</p>
        <p>Moreover, we calculated the mean RSFC of the regions that showed significantly altered RSFC with seed regions in the three group. Group differences were compared among the three groups using ANCOVA and <italic>post hoc</italic>
<italic>t</italic>-tests between any two groups using SPSS. To exclude the effects of global signal, we reanalyzed the mean RSFC using resting-state fMRI data without global signal regression.</p>
      </sec>
      <sec id="s2-8">
        <title>Correlation Analyses</title>
        <p>We also performed correlation analysis between neuroimaging measures (mean gray matter density and RSFC) and the clinical measures (MOCA and HAMD scores) to further explore whether neuroimaging indices were related to the symptom level, respectively, in svMCI+D and svMCI−D while controlling for age, gender, and education. The significance level was set at <italic>p</italic> &lt; 0.05.</p>
      </sec>
    </sec>
    <sec sec-type="results" id="s3">
      <title>Results</title>
      <sec id="s3-1">
        <title>Demographic Data and Clinical Measures</title>
        <p>The demographic and clinical measures were summarized in <xref rid="T1" ref-type="table">Table 1</xref>. No significant differences were found among the three groups in age, gender, and education (<italic>p</italic> &gt; 0.05). The MOCA scores of the svMCI+D were the smallest in the three groups, representing the heaviest cognitive impairment, while the HAMD scores of the svMCI+D were the highest in the three group, representing the heaviest depression.</p>
      </sec>
      <sec id="s3-2">
        <title>VBM Results</title>
        <p>Significantly altered gray matter density was identified in the left parahippocampus (ParaHIPP.L), the right hippocampus (HIPP.R), and the right middle cingulate cortex (MCC.R) among the three groups (<xref ref-type="fig" rid="F1">Figure 1A</xref> and <xref rid="T2" ref-type="table">Table 2</xref>).</p>
        <fig id="F1" position="float">
          <label>Figure 1</label>
          <caption>
            <p>Abnormal gray matter density in the whole brain <bold>(A)</bold> and regional-level <bold>(B)</bold> analyses among subcortical vascular mild cognitive impairment (svMCI) with depression symptoms (svMCI+D), svMCI without depression symptoms (svMCI−D), and normal control (NC). Analysis of covariance (ANCOVA), <italic>post hoc</italic>
<italic>t</italic>-tests and gaussian random field (GRF) correction (voxel level <italic>p</italic> &lt; 0.001, cluster level <italic>p</italic> &lt; 0.05) were used. *Significant at <italic>p</italic> &lt; 0.05. Abbreviations are listed in <xref rid="T2" ref-type="table">Table 2</xref>.</p>
          </caption>
          <graphic xlink:href="fnagi-11-00241-g0001"/>
        </fig>
        <table-wrap id="T2" position="float">
          <label>Table 2</label>
          <caption>
            <p>Abnormal gray matter density among svMCI with depression symptoms (svMCI+D), svMCI without depression symptoms (svMCI−D), and normal control (NC) using ANCOVA.</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th align="left" rowspan="1" colspan="1">Comparison</th>
                <th align="left" rowspan="1" colspan="1">Brain regions</th>
                <th align="center" rowspan="1" colspan="1">Cluster size</th>
                <th align="center" rowspan="1" colspan="1">Peak intensity</th>
                <th align="center" rowspan="1" colspan="1">Peak MNI coordinates</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" rowspan="1" colspan="1">svMCI+D and svMCI−D and NC</td>
                <td align="left" rowspan="1" colspan="1">ParaHIPP.L</td>
                <td align="center" rowspan="1" colspan="1">652</td>
                <td align="center" rowspan="1" colspan="1">14.0391</td>
                <td align="center" rowspan="1" colspan="1">(−19, −37, −3)</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">HIPP.R</td>
                <td align="center" rowspan="1" colspan="1">614</td>
                <td align="center" rowspan="1" colspan="1">11.5422</td>
                <td align="center" rowspan="1" colspan="1">(24, −33, −2)</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">MCC.R</td>
                <td align="center" rowspan="1" colspan="1">944</td>
                <td align="center" rowspan="1" colspan="1">19.88</td>
                <td align="center" rowspan="1" colspan="1">(3, −10, 28)</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <p><italic>Abbreviations: L, left; R, right; ParaHIPP, parahippocampus; HIPP, hippocampus</italic>.</p>
          </table-wrap-foot>
        </table-wrap>
        <p>For the three brain regions that showed significantly altered gray matter density among the three groups, group differences of regional mean gray matter density were investigated using <italic>post hoc</italic>
<italic>t</italic>-tests. Both the svMCI+D and svMCI−D group showed decreased mean gray matter density in the ParaHIPP.L, HIPP.R, and MCC.R compared to the NC. Moreover, we also found significantly increased mean gray matter density of the MCC.R in the svMCI+D compared to the svMCI−D (<xref ref-type="fig" rid="F1">Figure 1B</xref>).</p>
      </sec>
      <sec id="s3-3">
        <title>RSFC Results</title>
        <p>We found significantly increased RSFC between the MCC.R and right parahippocampus (ParaHIPP.R) in both the svMCI+D and svMCI−D groups compared to the NC (<xref ref-type="fig" rid="F2">Figure 2</xref>). However, compared to NC, the RSFC between the MCC.R and right cerebellum (CERE.R) was increased in the svMCI+D but decreased in the svMCI−D. The results were similar with and without global signal regression.</p>
        <fig id="F2" position="float">
          <label>Figure 2</label>
          <caption>
            <p>Abnormal resting-state functional connectivity (RSFC) among svMCI+D, svMCI−D, and NC. ANCOVA, <italic>post hoc</italic>
<italic>t</italic>-tests and GRF correction (voxel level <italic>p</italic> &lt; 0.001, cluster level <italic>p</italic> &lt; 0.05) were used. The mean RSFC of the altered brain regions were calculated both with and without global signal regression in the three groups, and <italic>post hoc</italic>
<italic>t</italic>-tests were performed between the RSFC of any two groups. **Significant at <italic>p</italic> &lt; 0.001. *Significant at <italic>p</italic> &lt; 0.05.</p>
          </caption>
          <graphic xlink:href="fnagi-11-00241-g0002"/>
        </fig>
      </sec>
      <sec id="s3-4">
        <title>Correlation Results</title>
        <p>While controlling for age, gender, and education, the MOCA scores of the svMCI+D were significantly correlated with the mean gray matter density of the MCC.R, and the HAMD scores of the svMCI−D were positively correlated with the mean gray matter density of the ParaHIPP.L (<xref ref-type="fig" rid="F3">Figure 3</xref>).</p>
        <fig id="F3" position="float">
          <label>Figure 3</label>
          <caption>
            <p>Correlation analysis. <bold>(A)</bold> Correlation analysis showed that the mean gray matter density of right middle cingulate cortex (MCC.R) was correlated with the montreal cognitive assessment (MOCA) score in svMCI+D patients (<italic>p</italic> &lt; 0.05). <bold>(B)</bold> Correlation analysis showed that the mean gray matter density of ParaHIPP.R was correlated with the HAMD score in svMCI−D patients (<italic>p</italic> &lt; 0.05).</p>
          </caption>
          <graphic xlink:href="fnagi-11-00241-g0003"/>
        </fig>
      </sec>
    </sec>
    <sec sec-type="discussion" id="s4">
      <title>Discussion</title>
      <p>Combining the VBM and RSFC, we identified significantly decreased gray matter density in the ParaHIPP.L, HIPP.R, and MCC.R in both the svMCI+D and svMCI−D compared to NC. Most importantly, we also identified increased gray matter density in the MCC.R accompanied by increased RSFC with ParaHIPP.R in the svMCI+D compared to the svMCI−D. Moreover, the gray matter density of MCC.R and ParaHIPP.L were correlated with cognitive impairments and depression symptoms in the svMCI, respectively.</p>
      <p>We identified significantly decreased gray matter density in the ParaHIPP.L and the HIPP.R in both the svMCI+D and svMCI−D compared to NC. Similar with our results, the structural disruptions of the HIPP.R, such as gray matter volume atrophy (Fein et al., <xref rid="B4" ref-type="bibr">2000</xref>; Li et al., <xref rid="B15" ref-type="bibr">2017</xref>), hippocampal subfield volume atrophy (Li et al., <xref rid="B17" ref-type="bibr">2016</xref>), hippocampal shape deformities (Kim et al., <xref rid="B11" ref-type="bibr">2014</xref>, <xref rid="B10" ref-type="bibr">2015</xref>), and altered structural covariance of the hippocampal subfields (Wang et al., <xref rid="B36" ref-type="bibr">2018</xref>), were identified in several neuroimaging studies in the svMCI. Recently, a VBM study also reported gray matter volume reductions in both the HIPP.R and the ParaHIPP.L in the svMCI compared to NC (Li et al., <xref rid="B15" ref-type="bibr">2017</xref>). In addition, the svMCI patients also showed elevated susceptibility values within the HIPP.R, which was negatively correlated with memory <italic>z</italic>-scores (Sun et al., <xref rid="B33" ref-type="bibr">2017</xref>). Since the HIPP and ParaHIPP are reported to be involved in memory consolidation (Runyan et al., <xref rid="B28" ref-type="bibr">2019</xref>), the decreased gray matter density in these two regions might be associated with memory loss in the svMCI. However, there were no memory measurements in our study, which weakens our interpretation.</p>
      <p>Most importantly, the gray matter density in the MCC.R was decreased in both the svMCI+D and svMCI−D compared to NC, but it was increased in the svMCI+D compared to the svMCI−D. On the one hand, the disruptions of MCC.R were in line with previous results, which showed significantly disrupted intramodular connectivity in the middle cingulate cortex (MCC) in the svMCI (Yi et al., <xref rid="B38" ref-type="bibr">2015</xref>) and reduced nodal efficiency in the MCC in late-life depression with comorbid amnestic MCI (Li et al., <xref rid="B16" ref-type="bibr">2015</xref>). On the other hand, the finding of increased gray matter density in the MCC in the svMCI+D compared to the svMCI−D is innovative and noteworthy. Moreover, further correlation analysis showed that the gray matter density of MCC.R is negatively correlated with MOCA scores of the svMCI+D, indicating that the higher gray matter density of the MCC.R, the more severe the cognitive impairment in the svMCI+D. Taken together, our results offered extra evidence to support the hypothesis that depression itself can primarily cause and/or worsen cognitive deficits in the MCI (Palmer et al., <xref rid="B21" ref-type="bibr">2010</xref>). More specifically, we suggested that the following processing loop might underlie the mechanism of depression symptoms in the svMCI: the svMCI showed decreased gray matter density in the HIPP.R and ParaHIPP.L, which might initially cause depression symptoms (association between the gray matter density of the ParaHIPP.L and HAMD scores in the patients with svMCI−D) and induce increased RSFC between the ParaHIPP.R and MCC.R, resulting in increased gray matter density of the MCC.R as time goes by, which finally worsens the cognitive impairments (association between the gray matter density of the MCC.R and MOCA scores in the patients with svMCI+D) and decreases the gray matter density of the HIPP.R and ParaHIPP.L in return. However, a longitudinal analysis that can provide more direct evidence is needed to confirm our suggestion.</p>
      <p>Moreover, two major limitations should be stressed in the current study. First, all patients had subcortical small infarcts (&lt;2 mm) and/or WML around the ventricle or randomly distributed in the whole brain. Since these lesions were relatively small and distributed randomly, it was extremely difficult to assess the location and volume of all the lesions and remove all of them. We processed the data as usual and did not control or consider the effects of these lesions. Thus, we cannot exclude the potential effects of lesions on our results. Second, the sample size is relatively small. A larger sample size is further needed to validate our results.</p>
    </sec>
    <sec id="s5">
      <title>Conclusion</title>
      <p>In conclusion, our results extended previous studies and added weight to considerations of depression symptoms in the svMCI. Moreover, we suggested that a processing loop associated with HIPP, ParaHIPP, and MCC might underlie the mechanism of depression symptoms in the svMCI.</p>
    </sec>
    <sec sec-type="data-availability" id="s6">
      <title>Data Availability</title>
      <p>The datasets generated for this study are available on request to the corresponding author.</p>
    </sec>
    <sec id="s7">
      <title>Ethics Statement</title>
      <p>The studies involving human participants were reviewed and approved by the Institutional Review Board of the Shenzhen Traditional Chinese Medicine Hospital. The patients/participants provided their written informed consent to participate in this study.</p>
    </sec>
    <sec id="s8">
      <title>Author Contributions</title>
      <p>YH and ZG designed the research. HL, JW, HZ, XY, SL, JC and LZ participated in the data collection. HL, JX and HZ analyzed the data. HL and JW wrote the manuscript. All authors read and approved the final manuscript.</p>
    </sec>
    <sec id="s9">
      <title>Conflict of Interest Statement</title>
      <p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="financial-disclosure">
        <p><bold>Funding.</bold> This study was sponsored by the Shenzhen Science and Technology Innovation Committee (Grant No. JCYJ20170307154620600), Sanming Project of Medicine in Shenzhen (Grant No. szsm201612081), the Natural Science Foundation of Guangdong Province (Grant No. 2017A030313744), and the National Key Research Program (Grant No. 2017YFC1703606).</p>
      </fn>
    </fn-group>
    <fn-group>
      <fn id="fn0001">
        <p>
          <sup>1</sup>
          <ext-link ext-link-type="uri" xlink:href="http://rfmri.org/dpabi">http://rfmri.org/dpabi</ext-link>
        </p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="B1">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>W.</given-names></name><name><surname>Cao</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Sun</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Zhou</surname><given-names>Y.</given-names></name><etal/></person-group>. (<year>2015</year>). <article-title>Altered functional connectivity in patients with subcortical vascular cognitive impairment—a resting-state functional magnetic resonance imaging study</article-title>. <source>PLoS One</source>
<volume>10</volume>:<fpage>e0138180</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0138180</pub-id><pub-id pub-id-type="pmid">26376180</pub-id></mixed-citation>
      </ref>
      <ref id="B2">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Enache</surname><given-names>D.</given-names></name><name><surname>Winblad</surname><given-names>B.</given-names></name><name><surname>Aarsland</surname><given-names>D.</given-names></name></person-group> (<year>2011</year>). <article-title>Depression in dementia: epidemiology, mechanisms, and treatment</article-title>. <source>Curr. Opin. Psychiatry</source>
<volume>24</volume>, <fpage>461</fpage>–<lpage>472</lpage>. <pub-id pub-id-type="doi">10.1097/yco.0b013e32834bb9d4</pub-id><pub-id pub-id-type="pmid">21926624</pub-id></mixed-citation>
      </ref>
      <ref id="B3">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fazekas</surname><given-names>F.</given-names></name><name><surname>Chawluk</surname><given-names>J. B.</given-names></name><name><surname>Alavi</surname><given-names>A.</given-names></name><name><surname>Hurtig</surname><given-names>H. I.</given-names></name><name><surname>Zimmerman</surname><given-names>R. A.</given-names></name></person-group> (<year>1987</year>). <article-title>MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging</article-title>. <source>AJR Am. J. Roentgenol.</source>
<volume>149</volume>, <fpage>351</fpage>–<lpage>356</lpage>. <pub-id pub-id-type="doi">10.2214/ajr.149.2.351</pub-id><pub-id pub-id-type="pmid">3496763</pub-id></mixed-citation>
      </ref>
      <ref id="B4">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fein</surname><given-names>G.</given-names></name><name><surname>Di Sclafani</surname><given-names>V.</given-names></name><name><surname>Tanabe</surname><given-names>J.</given-names></name><name><surname>Cardenas</surname><given-names>V.</given-names></name><name><surname>Weiner</surname><given-names>M. W.</given-names></name><name><surname>Jagust</surname><given-names>W. J.</given-names></name><etal/></person-group>. (<year>2000</year>). <article-title>Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease</article-title>. <source>Neurology</source>
<volume>55</volume>, <fpage>1626</fpage>–<lpage>1635</lpage>. <pub-id pub-id-type="doi">10.1212/wnl.55.11.1626</pub-id><pub-id pub-id-type="pmid">11113215</pub-id></mixed-citation>
      </ref>
      <ref id="B5">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frisoni</surname><given-names>G. B.</given-names></name><name><surname>Galluzzi</surname><given-names>S.</given-names></name><name><surname>Bresciani</surname><given-names>L.</given-names></name><name><surname>Zanetti</surname><given-names>O.</given-names></name><name><surname>Geroldi</surname><given-names>C.</given-names></name></person-group> (<year>2002</year>). <article-title>Mild cognitive impairment with subcortical vascular features clinical characteristics and outcome</article-title>. <source>J. Neurol.</source>
<volume>249</volume>, <fpage>1423</fpage>–<lpage>1432</lpage>. <pub-id pub-id-type="doi">10.1007/s00415-002-0861-7</pub-id><pub-id pub-id-type="pmid">12382161</pub-id></mixed-citation>
      </ref>
      <ref id="B6">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friston</surname><given-names>K. J.</given-names></name><name><surname>Williams</surname><given-names>S.</given-names></name><name><surname>Howard</surname><given-names>R.</given-names></name><name><surname>Frackowiak</surname><given-names>R. S.</given-names></name><name><surname>Turner</surname><given-names>R.</given-names></name></person-group> (<year>1996</year>). <article-title>Movement-related effects in fMRI time-series</article-title>. <source>Magn. Reson. Med.</source>
<volume>35</volume>, <fpage>346</fpage>–<lpage>355</lpage>. <pub-id pub-id-type="doi">10.1002/mrm.1910350312</pub-id><pub-id pub-id-type="pmid">8699946</pub-id></mixed-citation>
      </ref>
      <ref id="B7">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gabryelewicz</surname><given-names>T.</given-names></name><name><surname>Styczynska</surname><given-names>M.</given-names></name><name><surname>Luczywek</surname><given-names>E.</given-names></name><name><surname>Barczak</surname><given-names>A.</given-names></name><name><surname>Pfeffer</surname><given-names>A.</given-names></name><name><surname>Androsiuk</surname><given-names>W.</given-names></name><etal/></person-group>. (<year>2007</year>). <article-title>The rate of conversion of mild cognitive impairment to dementia: predictive role of depression</article-title>. <source>Int. J. Geriatr. Psychiatry</source>
<volume>22</volume>, <fpage>563</fpage>–<lpage>567</lpage>. <pub-id pub-id-type="doi">10.1002/gps.1716</pub-id><pub-id pub-id-type="pmid">17136705</pub-id></mixed-citation>
      </ref>
      <ref id="B8">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jak</surname><given-names>A. J.</given-names></name><name><surname>Bondi</surname><given-names>M. W.</given-names></name><name><surname>Delano-Wood</surname><given-names>L.</given-names></name><name><surname>Wierenga</surname><given-names>C.</given-names></name><name><surname>Corey-Bloom</surname><given-names>J.</given-names></name><name><surname>Salmon</surname><given-names>D. P.</given-names></name><etal/></person-group>. (<year>2009</year>). <article-title>Quantification of five neuropsychological approaches to defining mild cognitive impairment</article-title>. <source>Am. J. Geriatr. Psychiatry</source>
<volume>17</volume>, <fpage>368</fpage>–<lpage>375</lpage>. <pub-id pub-id-type="doi">10.1097/jgp.0b013e31819431d5</pub-id><pub-id pub-id-type="pmid">19390294</pub-id></mixed-citation>
      </ref>
      <ref id="B9">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jia</surname><given-names>J.</given-names></name><name><surname>Wei</surname><given-names>C.</given-names></name><name><surname>Liang</surname><given-names>J.</given-names></name><name><surname>Zhou</surname><given-names>A.</given-names></name><name><surname>Zuo</surname><given-names>X.</given-names></name><name><surname>Song</surname><given-names>H.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>The effects of DL-3-n-butylphthalide in patients with vascular cognitive impairment without dementia caused by subcortical ischemic small vessel disease: a multicentre, randomized, double-blind, placebo-controlled trial</article-title>. <source>Alzheimers Dement.</source>
<volume>12</volume>, <fpage>89</fpage>–<lpage>99</lpage>. <pub-id pub-id-type="doi">10.1016/j.jalz.2015.04.010</pub-id><pub-id pub-id-type="pmid">26086183</pub-id></mixed-citation>
      </ref>
      <ref id="B12">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>S. H.</given-names></name><name><surname>Kang</surname><given-names>H. S.</given-names></name><name><surname>Kim</surname><given-names>H. J.</given-names></name><name><surname>Ryu</surname><given-names>H. J.</given-names></name><name><surname>Kim</surname><given-names>M. Y.</given-names></name><name><surname>Seo</surname><given-names>S. W.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title>Neuropsychiatric predictors of conversion to dementia both in patients with amnestic mild cognitive impairment and those with subcortical vascular MCI</article-title>. <source>Clin. Neurol. Neurosurg.</source>
<volume>115</volume>, <fpage>1264</fpage>–<lpage>1270</lpage>. <pub-id pub-id-type="doi">10.1016/j.clineuro.2012.11.029</pub-id><pub-id pub-id-type="pmid">23290121</pub-id></mixed-citation>
      </ref>
      <ref id="B10">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>G. H.</given-names></name><name><surname>Lee</surname><given-names>J. H.</given-names></name><name><surname>Seo</surname><given-names>S. W.</given-names></name><name><surname>Kim</surname><given-names>J. H.</given-names></name><name><surname>Seong</surname><given-names>J. K.</given-names></name><name><surname>Ye</surname><given-names>B. S.</given-names></name><etal/></person-group>. (<year>2015</year>). <article-title>Hippocampal volume and shape in pure subcortical vascular dementia</article-title>. <source>Neurobiol. Aging</source>
<volume>36</volume>, <fpage>485</fpage>–<lpage>491</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2014.08.009</pub-id><pub-id pub-id-type="pmid">25444608</pub-id></mixed-citation>
      </ref>
      <ref id="B13">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>S. H.</given-names></name><name><surname>Park</surname><given-names>J. S.</given-names></name><name><surname>Ahn</surname><given-names>H. J.</given-names></name><name><surname>Seo</surname><given-names>S. W.</given-names></name><name><surname>Lee</surname><given-names>J. M.</given-names></name><name><surname>Kim</surname><given-names>S. T.</given-names></name><etal/></person-group>. (<year>2011</year>). <article-title>Voxel-based analysis of diffusion tensor imaging in patients with subcortical vascular cognitive impairment: correlates with cognitive and motor deficits</article-title>. <source>J. Neuroimaging</source>
<volume>21</volume>, <fpage>317</fpage>–<lpage>324</lpage>. <pub-id pub-id-type="doi">10.1111/j.1552-6569.2010.00527.x</pub-id><pub-id pub-id-type="pmid">20977535</pub-id></mixed-citation>
      </ref>
      <ref id="B11">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>H. J.</given-names></name><name><surname>Ye</surname><given-names>B. S.</given-names></name><name><surname>Yoon</surname><given-names>C. W.</given-names></name><name><surname>Noh</surname><given-names>Y.</given-names></name><name><surname>Kim</surname><given-names>G. H.</given-names></name><name><surname>Cho</surname><given-names>H.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>Cortical thickness and hippocampal shape in pure vascular mild cognitive impairment and dementia of subcortical type</article-title>. <source>Eur. J. Neurol.</source>
<volume>21</volume>, <fpage>744</fpage>–<lpage>751</lpage>. <pub-id pub-id-type="doi">10.1111/ene.12376</pub-id><pub-id pub-id-type="pmid">24495089</pub-id></mixed-citation>
      </ref>
      <ref id="B14">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>J.</given-names></name><name><surname>Seo</surname><given-names>S. W.</given-names></name><name><surname>Yang</surname><given-names>J. J.</given-names></name><name><surname>Jang</surname><given-names>Y. K.</given-names></name><name><surname>Lee</surname><given-names>J. S.</given-names></name><name><surname>Kim</surname><given-names>Y. J.</given-names></name><etal/></person-group>. (<year>2018</year>). <article-title>Longitudinal cortical thinning and cognitive decline in patients with early- versus late-stage subcortical vascular mild cognitive impairment</article-title>. <source>Eur. J. Neurol.</source>
<volume>25</volume>, <fpage>326</fpage>–<lpage>333</lpage>. <pub-id pub-id-type="doi">10.1111/ene.13500</pub-id><pub-id pub-id-type="pmid">29082576</pub-id></mixed-citation>
      </ref>
      <ref id="B16">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Douglas Ward</surname><given-names>B.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Chen</surname><given-names>G.</given-names></name><name><surname>Jones</surname><given-names>J. L.</given-names></name><name><surname>Antuono</surname><given-names>P. G.</given-names></name><etal/></person-group>. (<year>2015</year>). <article-title>Disrupted small world topology and modular organisation of functional networks in late-life depression with and without amnestic mild cognitive impairment</article-title>. <source>J. Neurol. Neurosurg. Psychiatry</source>
<volume>86</volume>, <fpage>1097</fpage>–<lpage>1105</lpage>. <pub-id pub-id-type="doi">10.1136/jnnp-2014-309180</pub-id><pub-id pub-id-type="pmid">25433036</pub-id></mixed-citation>
      </ref>
      <ref id="B17">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>D.</given-names></name><name><surname>Li</surname><given-names>Q.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>K.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>Hippocampal subfield volumetry in patients with subcortical vascular mild cognitive impairment</article-title>. <source>Sci. Rep.</source>
<volume>6</volume>:<fpage>20873</fpage>. <pub-id pub-id-type="doi">10.1038/srep20873</pub-id><pub-id pub-id-type="pmid">26876151</pub-id></mixed-citation>
      </ref>
      <ref id="B15">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>M.</given-names></name><name><surname>Meng</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>M.</given-names></name><name><surname>Yang</surname><given-names>S.</given-names></name><name><surname>Wu</surname><given-names>H.</given-names></name><name><surname>Zhao</surname><given-names>B.</given-names></name><etal/></person-group>. (<year>2017</year>). <article-title>Cerebral gray matter volume reduction in subcortical vascular mild cognitive impairment patients and subcortical vascular dementia patients and its relation with cognitive deficits</article-title>. <source>Brain Behav.</source>
<volume>7</volume>:<fpage>e00745</fpage>. <pub-id pub-id-type="doi">10.1002/brb3.745</pub-id><pub-id pub-id-type="pmid">28828207</pub-id></mixed-citation>
      </ref>
      <ref id="B18">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X. Z.</given-names></name><name><surname>Tu</surname><given-names>Y. H.</given-names></name><name><surname>Zang</surname><given-names>Y. R.</given-names></name><name><surname>Wu</surname><given-names>A. Q.</given-names></name><name><surname>Guo</surname><given-names>Z. W.</given-names></name><name><surname>He</surname><given-names>J. W.</given-names></name></person-group> (<year>2019</year>). <article-title>Disrupted regional spontaneous neural activity in mild cognitive impairment patients with depressive symptoms: a resting-state fMRI study</article-title>. <source>Neural Plast.</source>
<volume>2019</volume>:<fpage>2981764</fpage>. <pub-id pub-id-type="doi">10.1155/2019/2981764</pub-id><pub-id pub-id-type="pmid">30728833</pub-id></mixed-citation>
      </ref>
      <ref id="B19">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orgeta</surname><given-names>V.</given-names></name><name><surname>Qazi</surname><given-names>A.</given-names></name><name><surname>Spector</surname><given-names>A.</given-names></name><name><surname>Orrell</surname><given-names>M.</given-names></name></person-group> (<year>2015</year>). <article-title>Psychological treatments for depression and anxiety in dementia and mild cognitive impairment: systematic review and meta-analysis</article-title>. <source>Br. J. Psychiatry</source>
<volume>207</volume>, <fpage>293</fpage>–<lpage>298</lpage>. <pub-id pub-id-type="doi">10.1192/bjp.bp.114.148130</pub-id><pub-id pub-id-type="pmid">26429684</pub-id></mixed-citation>
      </ref>
      <ref id="B20">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palmer</surname><given-names>K.</given-names></name><name><surname>Berger</surname><given-names>A. K.</given-names></name><name><surname>Monastero</surname><given-names>R.</given-names></name><name><surname>Winblad</surname><given-names>B.</given-names></name><name><surname>Bäckman</surname><given-names>L.</given-names></name><name><surname>Fratiglioni</surname><given-names>L.</given-names></name></person-group> (<year>2007</year>). <article-title>Predictors of progression from mild cognitive impairment to Alzheimer disease</article-title>. <source>Neurology</source>
<volume>68</volume>, <fpage>1596</fpage>–<lpage>1602</lpage>. <pub-id pub-id-type="doi">10.1212/01.wnl.0000260968.92345.3f</pub-id><pub-id pub-id-type="pmid">17485646</pub-id></mixed-citation>
      </ref>
      <ref id="B21">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palmer</surname><given-names>K.</given-names></name><name><surname>Di Iulio</surname><given-names>F.</given-names></name><name><surname>Varsi</surname><given-names>A. E.</given-names></name><name><surname>Gianni</surname><given-names>W.</given-names></name><name><surname>Sancesario</surname><given-names>G.</given-names></name><name><surname>Caltagirone</surname><given-names>C.</given-names></name><etal/></person-group>. (<year>2010</year>). <article-title>Neuropsychiatric predictors of progression from amnestic-mild cognitive impairment to Alzheimer’s disease: the role of depression and apathy</article-title>. <source>J. Alzheimers Dis.</source>
<volume>20</volume>, <fpage>175</fpage>–<lpage>183</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-2010-1352</pub-id><pub-id pub-id-type="pmid">20164594</pub-id></mixed-citation>
      </ref>
      <ref id="B22">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pavlovic</surname><given-names>A. M.</given-names></name><name><surname>Pekmezovic</surname><given-names>T.</given-names></name><name><surname>Zidverc Trajkovic</surname><given-names>J.</given-names></name><name><surname>Svabic Medjedovic</surname><given-names>T.</given-names></name><name><surname>Veselinovic</surname><given-names>N.</given-names></name><name><surname>Radojicic</surname><given-names>A.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>Baseline characteristic of patients presenting with lacunar stroke and cerebral small vessel disease may predict future development of depression</article-title>. <source>Int. J. Geriatr. Psychiatry</source>
<volume>31</volume>, <fpage>58</fpage>–<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1002/gps.4289</pub-id><pub-id pub-id-type="pmid">25821003</pub-id></mixed-citation>
      </ref>
      <ref id="B23">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petersen</surname><given-names>R. C.</given-names></name></person-group> (<year>2004</year>). <article-title>Mild cognitive impairment as a diagnostic entity</article-title>. <source>J. Intern. Med.</source>
<volume>256</volume>, <fpage>183</fpage>–<lpage>194</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2796.2004.01388.x</pub-id><pub-id pub-id-type="pmid">15324362</pub-id></mixed-citation>
      </ref>
      <ref id="B24">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Power</surname><given-names>J. D.</given-names></name><name><surname>Barnes</surname><given-names>K. A.</given-names></name><name><surname>Snyder</surname><given-names>A. Z.</given-names></name><name><surname>Schlaggar</surname><given-names>B. L.</given-names></name><name><surname>Petersen</surname><given-names>S. E.</given-names></name></person-group> (<year>2012</year>). <article-title>Spurious but systematic correlations in functional connectivity MRI networks arise from subject motion</article-title>. <source>Neuroimage</source>
<volume>59</volume>, <fpage>2142</fpage>–<lpage>2154</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2011.10.018</pub-id><pub-id pub-id-type="pmid">22019881</pub-id></mixed-citation>
      </ref>
      <ref id="B25">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ravaglia</surname><given-names>G.</given-names></name><name><surname>Forti</surname><given-names>P.</given-names></name><name><surname>Maioli</surname><given-names>F.</given-names></name><name><surname>Martelli</surname><given-names>M.</given-names></name><name><surname>Servadei</surname><given-names>L.</given-names></name><name><surname>Brunetti</surname><given-names>N.</given-names></name><etal/></person-group>. (<year>2006</year>). <article-title>Conversion of mild cognitive impairment to dementia: predictive role of mild cognitive impairment subtypes and vascular risk factors</article-title>. <source>Dement. Geriatr. Cogn. Disord.</source>
<volume>21</volume>, <fpage>51</fpage>–<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1159/000089515</pub-id><pub-id pub-id-type="pmid">16276110</pub-id></mixed-citation>
      </ref>
      <ref id="B26">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riedel</surname><given-names>M.</given-names></name><name><surname>Moller</surname><given-names>H. J.</given-names></name><name><surname>Obermeier</surname><given-names>M.</given-names></name><name><surname>Schennach-Wolff</surname><given-names>R.</given-names></name><name><surname>Bauer</surname><given-names>M.</given-names></name><name><surname>Adli</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2010</year>). <article-title>Response and remission criteria in major depression—a validation of current practice</article-title>. <source>J. Psychiatr. Res.</source>
<volume>44</volume>, <fpage>1063</fpage>–<lpage>1068</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpsychires.2010.03.006</pub-id><pub-id pub-id-type="pmid">20447651</pub-id></mixed-citation>
      </ref>
      <ref id="B27">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenberg</surname><given-names>P. B.</given-names></name><name><surname>Mielke</surname><given-names>M. M.</given-names></name><name><surname>Appleby</surname><given-names>B. S.</given-names></name><name><surname>Oh</surname><given-names>E. S.</given-names></name><name><surname>Geda</surname><given-names>Y. E.</given-names></name><name><surname>Lyketsos</surname><given-names>C. G.</given-names></name></person-group> (<year>2013</year>). <article-title>The association of neuropsychiatric symptoms in MCI with incident dementia and Alzheimer disease</article-title>. <source>Am. J. Geriatr. Psychiatry</source>
<volume>21</volume>, <fpage>685</fpage>–<lpage>695</lpage>. <pub-id pub-id-type="doi">10.1016/j.jagp.2013.01.006</pub-id><pub-id pub-id-type="pmid">23567400</pub-id></mixed-citation>
      </ref>
      <ref id="B28">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Runyan</surname><given-names>J. D.</given-names></name><name><surname>Moore</surname><given-names>A. N.</given-names></name><name><surname>Dash</surname><given-names>P. K.</given-names></name></person-group> (<year>2019</year>). <article-title>Coordinating what we’ve learned about memory consolidation: revisiting a unified theory</article-title>. <source>Neurosci. Biobehav. Rev.</source>
<volume>100</volume>, <fpage>77</fpage>–<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1016/j.neubiorev.2019.02.010</pub-id><pub-id pub-id-type="pmid">30790633</pub-id></mixed-citation>
      </ref>
      <ref id="B29">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Satterthwaite</surname><given-names>T. D.</given-names></name><name><surname>Elliott</surname><given-names>M. A.</given-names></name><name><surname>Gerraty</surname><given-names>R. T.</given-names></name><name><surname>Ruparel</surname><given-names>K.</given-names></name><name><surname>Loughead</surname><given-names>J.</given-names></name><name><surname>Calkins</surname><given-names>M. E.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title>An improved framework for confound regression and filtering for control of motion artifact in the preprocessing of resting-state functional connectivity data</article-title>. <source>Neuroimage</source>
<volume>64</volume>, <fpage>240</fpage>–<lpage>256</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2012.08.052</pub-id><pub-id pub-id-type="pmid">22926292</pub-id></mixed-citation>
      </ref>
      <ref id="B30">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scheltens</surname><given-names>P.</given-names></name><name><surname>van de Pol</surname><given-names>L.</given-names></name></person-group> (<year>2012</year>). <article-title>Atrophy of medial temporal lobes on MRI in “probable” Alzheimer’s disease and normal ageing: diagnostic value and neuropsychological correlates</article-title>. <source>J. Neurol. Neurosurg. Psychiatry</source>
<volume>83</volume>, <fpage>1038</fpage>–<lpage>1040</lpage>. <pub-id pub-id-type="doi">10.1136/jnnp-2012-302562</pub-id><pub-id pub-id-type="pmid">22566596</pub-id></mixed-citation>
      </ref>
      <ref id="B31">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seo</surname><given-names>S. W.</given-names></name><name><surname>Ahn</surname><given-names>J.</given-names></name><name><surname>Yoon</surname><given-names>U.</given-names></name><name><surname>Im</surname><given-names>K.</given-names></name><name><surname>Lee</surname><given-names>J. M.</given-names></name><name><surname>Kim</surname><given-names>S. T.</given-names></name><etal/></person-group>. (<year>2010</year>). <article-title>Cortical thinning in vascular mild cognitive impairment and vascular dementia of subcortical type</article-title>. <source>J. Neuroimaging</source>
<volume>20</volume>, <fpage>37</fpage>–<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1111/j.1552-6569.2008.00293.x</pub-id><pub-id pub-id-type="pmid">19220710</pub-id></mixed-citation>
      </ref>
      <ref id="B32">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Solfrizzi</surname><given-names>V.</given-names></name><name><surname>D’introno</surname><given-names>A.</given-names></name><name><surname>Colacicco</surname><given-names>A. M.</given-names></name><name><surname>Capurso</surname><given-names>C.</given-names></name><name><surname>Del Parigi</surname><given-names>A.</given-names></name><name><surname>Caselli</surname><given-names>R. J.</given-names></name><etal/></person-group>. (<year>2007</year>). <article-title>Incident occurrence of depressive symptoms among patients with mild cognitive impairment—the Italian longitudinal study on Aging</article-title>. <source>Dement. Geriatr. Cogn. Disord.</source>
<volume>24</volume>, <fpage>55</fpage>–<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1159/000103632</pub-id><pub-id pub-id-type="pmid">17565214</pub-id></mixed-citation>
      </ref>
      <ref id="B33">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>Y. W.</given-names></name><name><surname>Ge</surname><given-names>X.</given-names></name><name><surname>Han</surname><given-names>X.</given-names></name><name><surname>Cao</surname><given-names>W. W.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Ding</surname><given-names>W. N.</given-names></name><etal/></person-group>. (<year>2017</year>). <article-title>Characterizing brain iron deposition in patients with subcortical vascular mild cognitive impairment using quantitative susceptibility mapping: a potential biomarker</article-title>. <source>Front. Aging Neurosci.</source>
<volume>9</volume>:<fpage>81</fpage>. <pub-id pub-id-type="doi">10.3389/fnagi.2017.00081</pub-id><pub-id pub-id-type="pmid">28424610</pub-id></mixed-citation>
      </ref>
      <ref id="B34">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teng</surname><given-names>E.</given-names></name><name><surname>Lu</surname><given-names>P. H.</given-names></name><name><surname>Cummings</surname><given-names>J. L.</given-names></name></person-group> (<year>2007</year>). <article-title>Neuropsychiatric symptoms are associated with progression from mild cognitive impairment to Alzheimer’s disease</article-title>. <source>Dement. Geriatr. Cogn. Disord.</source>
<volume>24</volume>, <fpage>253</fpage>–<lpage>259</lpage>. <pub-id pub-id-type="doi">10.1159/000107100</pub-id><pub-id pub-id-type="pmid">17700021</pub-id></mixed-citation>
      </ref>
      <ref id="B35">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vloeberghs</surname><given-names>R.</given-names></name><name><surname>Opmeer</surname><given-names>E. M.</given-names></name><name><surname>De Deyn</surname><given-names>P. P.</given-names></name><name><surname>Engelborghs</surname><given-names>S.</given-names></name><name><surname>De Roeck</surname><given-names>E. E.</given-names></name></person-group> (<year>2018</year>). <article-title>[Apathy, depression and cognitive functioning in patients with MCI and dementia]</article-title>. <source>Tijdschr. Gerontol. Geriatr.</source>
<volume>49</volume>, <fpage>95</fpage>–<lpage>102</lpage>. <pub-id pub-id-type="doi">10.1007/s12439-018-0248-6</pub-id><pub-id pub-id-type="pmid">29488192</pub-id></mixed-citation>
      </ref>
      <ref id="B36">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Yu</surname><given-names>Y.</given-names></name><name><surname>Zhao</surname><given-names>W.</given-names></name><name><surname>Li</surname><given-names>Q.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><etal/></person-group>. (<year>2018</year>). <article-title>Altered whole-brain structural covariance of the hippocampal subfields in subcortical vascular mild cognitive impairment and amnestic mild cognitive impairment patients</article-title>. <source>Front. Neurol.</source>
<volume>9</volume>:<fpage>342</fpage>. <pub-id pub-id-type="doi">10.3389/fneur.2018.00342</pub-id><pub-id pub-id-type="pmid">29872419</pub-id></mixed-citation>
      </ref>
      <ref id="B37">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>C. G.</given-names></name><name><surname>Cheung</surname><given-names>B.</given-names></name><name><surname>Kelly</surname><given-names>C.</given-names></name><name><surname>Colcombe</surname><given-names>S.</given-names></name><name><surname>Craddock</surname><given-names>R. C.</given-names></name><name><surname>Di Martino</surname><given-names>A.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title>A comprehensive assessment of regional variation in the impact of head micromovements on functional connectomics</article-title>. <source>Neuroimage</source>
<volume>76</volume>, <fpage>183</fpage>–<lpage>201</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2013.03.004</pub-id><pub-id pub-id-type="pmid">23499792</pub-id></mixed-citation>
      </ref>
      <ref id="B38">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yi</surname><given-names>L. Y.</given-names></name><name><surname>Liang</surname><given-names>X.</given-names></name><name><surname>Liu</surname><given-names>D. M.</given-names></name><name><surname>Sun</surname><given-names>B.</given-names></name><name><surname>Ying</surname><given-names>S.</given-names></name><name><surname>Yang</surname><given-names>D. B.</given-names></name><etal/></person-group>. (<year>2015</year>). <article-title>Disrupted topological organization of resting-state functional brain network in subcortical vascular mild cognitive impairment</article-title>. <source>CNS Neurosci. Ther.</source>
<volume>21</volume>, <fpage>846</fpage>–<lpage>854</lpage>. <pub-id pub-id-type="doi">10.1111/cns.12424</pub-id><pub-id pub-id-type="pmid">26257386</pub-id></mixed-citation>
      </ref>
      <ref id="B39">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yi</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Jia</surname><given-names>L.</given-names></name><name><surname>Zhao</surname><given-names>Z.</given-names></name><name><surname>Lu</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>K.</given-names></name><etal/></person-group>. (<year>2012</year>). <article-title>Structural and functional changes in subcortical vascular mild cognitive impairment: a combined voxel-based morphometry and resting-state fMRI study</article-title>. <source>PLoS One</source>
<volume>7</volume>:<fpage>e44758</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0044758</pub-id><pub-id pub-id-type="pmid">23028606</pub-id></mixed-citation>
      </ref>
      <ref id="B40">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>X.</given-names></name><name><surname>Hu</surname><given-names>X. P.</given-names></name><name><surname>Zhang</surname><given-names>C.</given-names></name><name><surname>Wang</surname><given-names>H. B.</given-names></name><name><surname>Zhu</surname><given-names>X. Q.</given-names></name><name><surname>Xu</surname><given-names>L. Y.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>Aberrant functional connectivity and structural atrophy in subcortical vascular cognitive impairment: relationship with cognitive impairments</article-title>. <source>Front. Aging Neurosci.</source>
<volume>8</volume>:<fpage>14</fpage>. <pub-id pub-id-type="doi">10.3389/fnagi.2016.00014</pub-id><pub-id pub-id-type="pmid">26869922</pub-id></mixed-citation>
      </ref>
      <ref id="B41">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zimmerman</surname><given-names>M.</given-names></name><name><surname>Martinez</surname><given-names>J. H.</given-names></name><name><surname>Young</surname><given-names>D.</given-names></name><name><surname>Chelminski</surname><given-names>I.</given-names></name><name><surname>Dalrymple</surname><given-names>K.</given-names></name></person-group> (<year>2013</year>). <article-title>Severity classification on the hamilton depression rating scale</article-title>. <source>J. Affect. Disord.</source>
<volume>150</volume>, <fpage>384</fpage>–<lpage>388</lpage>. <pub-id pub-id-type="doi">10.1016/j.jad.2013.04.028</pub-id><pub-id pub-id-type="pmid">23759278</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
